167 related articles for article (PubMed ID: 12447997)
1. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells.
Kue PF; Taub JS; Harrington LB; Polakiewicz RD; Ullrich A; Daaka Y
Int J Cancer; 2002 Dec; 102(6):572-9. PubMed ID: 12447997
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
[TBL] [Abstract][Full Text] [Related]
3. Essential role for G proteins in prostate cancer cell growth and signaling.
Kue PF; Daaka Y
J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.
Gschwind A; Prenzel N; Ullrich A
Cancer Res; 2002 Nov; 62(21):6329-36. PubMed ID: 12414665
[TBL] [Abstract][Full Text] [Related]
5. Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells.
Iacopino F; Lama G; Angelucci C; Sica G
Int J Oncol; 2006 Jul; 29(1):237-47. PubMed ID: 16773205
[TBL] [Abstract][Full Text] [Related]
6. Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases.
Zhao Y; He D; Saatian B; Watkins T; Spannhake EW; Pyne NJ; Natarajan V
J Biol Chem; 2006 Jul; 281(28):19501-11. PubMed ID: 16687414
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor.
Shah BH; Baukal AJ; Shah FB; Catt KJ
Mol Endocrinol; 2005 Oct; 19(10):2535-48. PubMed ID: 15928312
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines.
Guo C; Luttrell LM; Price DT
J Urol; 2000 Mar; 163(3):1027-32. PubMed ID: 10688043
[TBL] [Abstract][Full Text] [Related]
9. Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation.
Yano S; Macleod RJ; Chattopadhyay N; Tfelt-Hansen J; Kifor O; Butters RR; Brown EM
Bone; 2004 Sep; 35(3):664-72. PubMed ID: 15336602
[TBL] [Abstract][Full Text] [Related]
10. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
[TBL] [Abstract][Full Text] [Related]
11. Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells.
Santiskulvong C; Rozengurt E
Exp Cell Res; 2003 Nov; 290(2):437-46. PubMed ID: 14568001
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
13. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
Hassan S; Dobner PR; Carraway RE
Regul Pept; 2004 Aug; 120(1-3):155-66. PubMed ID: 15177934
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid-induced ERK activation and chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF receptor transactivation.
Karagiosis SA; Chrisler WB; Bollinger N; Karin NJ
J Cell Physiol; 2009 Jun; 219(3):716-23. PubMed ID: 19189345
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid induces rapid and sustained decreases in epidermal growth factor receptor binding via different signaling pathways in BEAS-2B airway epithelial cells.
Kassel KM; Dodmane PR; Schulte NA; Toews ML
J Pharmacol Exp Ther; 2008 Jun; 325(3):809-17. PubMed ID: 18309089
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic action of LPA in prostate.
Daaka Y
Biochim Biophys Acta; 2002 May; 1582(1-3):265-9. PubMed ID: 12069837
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid-induced effects in human colon carcinoma DLD1 cells are partially dependent on transactivation of epidermal growth factor receptor.
Mori K; Kitayama J; Shida D; Yamashita H; Watanabe T; Nagawa H
J Surg Res; 2006 May; 132(1):56-61. PubMed ID: 16289596
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid decreases epidermal growth factor receptor binding in airway epithelial cells.
Kassel KM; Schulte NA; Parker SM; Lanik AD; Toews ML
J Pharmacol Exp Ther; 2007 Oct; 323(1):109-18. PubMed ID: 17640953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
